克拉霉素纳米粒作为胶体药物递送系统的理化性质和抗菌性能表征。

Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.

机构信息

Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.

出版信息

Colloids Surf B Biointerfaces. 2011 Nov 1;88(1):39-44. doi: 10.1016/j.colsurfb.2011.05.050. Epub 2011 Jun 17.

Abstract

The objective of the present study was to prepare clarithromycin (CLR) loaded biodegradable nanoparticles (NPS), with a view to investigate its physicochemical properties and anti-bacterial activity. PLGA was used as a biodegradable polymer and the particles were prepared by nano-precipitation method in 3 different drugs to polymer ratios. Evaluation of the physicochemical properties of the prepared nanoparticles was performed using encapsulation efficiency, nanoparticle production yield, dissolution studies, particle size analysis, zeta potential determination, differential scanning calorimetry, Fourier-transform infrared spectroscopy and X-ray powder diffractometry. The antimicrobial activity against Staphylococcus aureus was determined using serial dilution technique to achieve the minimum inhibitory concentration (MIC) of NPs. The particles were between 189 and 280 nm in size with narrow size distribution, spherical shape and 57.4-80.2% entrapment efficiency. Zeta potential of the NPs was fairly negative. The DSC thermograms and X-ray diffraction patterns revealed reduced drug crystallinity in the NPs. FT-IR spectroscopy demonstrated possible noncovalent interactions between the drug and polymer. In vitro release study showed an initial burst followed by a plateau during a period of 24h. The NPs were more effective than intact CLR against S. aureus so that the former showed equal antibacterial effect at 1/8 concentration of the intact drug. In conclusion, the prepared CLR nanoparticles are more potent against S. aureus with improved MICs and appropriate physicochemical properties that may be useful for other susceptible microorganisms and could be an appropriate candidate for intravenous, ocular and oral and topical preparations.

摘要

本研究的目的是制备克拉霉素(CLR)负载的可生物降解纳米颗粒(NPS),以研究其理化性质和抗菌活性。PLGA 被用作可生物降解的聚合物,并且通过纳米沉淀法在 3 种不同的药物-聚合物比例下制备颗粒。使用包封效率、纳米颗粒产率、溶解研究、粒径分析、Zeta 电位测定、差示扫描量热法、傅里叶变换红外光谱和 X 射线粉末衍射法对制备的纳米颗粒的理化性质进行评估。使用连续稀释技术测定纳米颗粒对金黄色葡萄球菌的抗菌活性,以确定 NPs 的最小抑菌浓度(MIC)。颗粒的粒径在 189nm 至 280nm 之间,粒径分布较窄,呈球形,包封效率为 57.4-80.2%。NPs 的 Zeta 电位相当负。DSC 热图谱和 X 射线衍射图谱显示药物在 NPs 中结晶度降低。傅里叶变换红外光谱表明药物与聚合物之间可能存在非共价相互作用。体外释放研究表明,在 24 小时内,初始突释后出现平台期。纳米颗粒比完整的 CLR 对金黄色葡萄球菌更有效,前者在完整药物浓度的 1/8 时表现出相同的抗菌效果。总之,与完整的 CLR 相比,制备的克拉霉素纳米颗粒对金黄色葡萄球菌更有效,具有改善的 MIC 和适当的理化性质,可能对其他敏感的微生物有用,并且可以成为静脉内、眼部和口服以及局部制剂的合适候选物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索